390 related articles for article (PubMed ID: 11552256)
1. [What other effects do statins have except their effect on lipids?].
Tikkanen MJ
Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256
[No Abstract] [Full Text] [Related]
2. [Clinical trials on protective efficacy of statins for cardiovascular events due to hyperlipidemia (J-LIT, 4S, CARE, LIPID etc)].
Higashikata T
Nihon Rinsho; 2004 Mar; 62 Suppl 3():628-36. PubMed ID: 15171447
[No Abstract] [Full Text] [Related]
3. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
[TBL] [Abstract][Full Text] [Related]
4. Vascular health: the emerging appreciation of the endothelium.
Talley JD
J Ark Med Soc; 1997 Feb; 93(9):454-5. PubMed ID: 9046759
[No Abstract] [Full Text] [Related]
5. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
Motz W
MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
[No Abstract] [Full Text] [Related]
6. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
[TBL] [Abstract][Full Text] [Related]
7. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents].
De Caterina R; Lenzi S
G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058
[TBL] [Abstract][Full Text] [Related]
8. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.
Manuel DG; Tanuseputro P; Mustard CA; Schultz SE; Anderson GM; Ardal S; Alter DA; Laupacis A
CMAJ; 2005 Apr; 172(8):1027-31. PubMed ID: 15824409
[No Abstract] [Full Text] [Related]
9. [Pleiotropic effects of statins].
Westerweel PE; Verhaar MC; Rabelink TJ
Ned Tijdschr Geneeskd; 2004 Jul; 148(29):1431-5. PubMed ID: 15326645
[TBL] [Abstract][Full Text] [Related]
10. [Significance of setting standards and guidelines for management of patients with hyperlipidemia].
Kotake H; Oikawa S
Nihon Rinsho; 2001 Mar; 59 Suppl 3():492-9. PubMed ID: 11347119
[No Abstract] [Full Text] [Related]
11. [ALLHAT].
Ando K
Nihon Rinsho; 2006 Aug; 64 Suppl 6():402-7. PubMed ID: 16981570
[No Abstract] [Full Text] [Related]
12. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
Svilaas A; Strandberg T; Eriksson M; Hildebrandt P; Westheim A
Scand Cardiovasc J; 2008 Aug; 42(4):279-87. PubMed ID: 18609053
[TBL] [Abstract][Full Text] [Related]
13. Summary of the role of statins in the treatment of dyslipidemia.
Carr LL
J Am Osteopath Assoc; 2003 Jul; 103(7 Suppl 3):S1-3. PubMed ID: 12884937
[No Abstract] [Full Text] [Related]
14. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
[No Abstract] [Full Text] [Related]
15. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
Behrens GM
N Engl J Med; 2005 Apr; 352(16):1721-2; author reply 1721-2. PubMed ID: 15843678
[No Abstract] [Full Text] [Related]
16. [Treatment of dyslipidemia].
Cybulska B
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():11-2. PubMed ID: 12621774
[No Abstract] [Full Text] [Related]
17. Clinical aspects of dyslipidemia.
Kashyap M
Manag Care; 2001 Nov; 10(11 Suppl):4-9; discussion 19-24. PubMed ID: 11761628
[No Abstract] [Full Text] [Related]
18. [Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment].
Cullen P; Schulte H; Assmann G
Dtsch Med Wochenschr; 2005 Sep; 130(39):2220-5. PubMed ID: 16189760
[No Abstract] [Full Text] [Related]
19. Statins and the acute-phase response.
Munford RS
N Engl J Med; 2001 Jun; 344(26):2016-8. PubMed ID: 11430332
[No Abstract] [Full Text] [Related]
20. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
Hou R; Goldberg AC
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
